Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome.
Arch Intern Med
; 149(11): 2501-3, 1989 Nov.
Article
en En
| MEDLINE
| ID: mdl-2684076
Chronic fatigue syndrome is a recently defined entity for which clinical criteria were proposed by the Centers for Disease Control, Atlanta, Ga. A frequently advocated treatment in Southern California is an injectable solution of bovine liver extract containing folic acid and cyanocobalamin (LEFAC). We conducted a double-blind, placebo-controlled, crossover trial of intramuscular LEFAC in 15 patients who met the Centers for Disease Control criteria for chronic fatigue syndrome. Although patients responded to placebo and LEFAC by several criteria of functional status, no significant difference was apparent between response to placebo and that to LEFAC. The placebo response appeared to be strong.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Vitamina B 12
/
Síndrome de Fatiga Crónica
/
Ácido Fólico
/
Extractos Hepáticos
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Arch Intern Med
Año:
1989
Tipo del documento:
Article